Endocrine Abstracts

Introduction: Our aim was to collect demographic data of diabetes mellitus (DM) patients to determine the patients education, follow-up and treatment priorities.

Material-Method: 500 patients with diagnosis of DM followed up at least 6 months were included the study. Datas containing patients demographic characteristics, treatment modalities, biochemical parameters were retrospectively reviewed. On the day of admission patients; fasting blood glucose (FBG), postprandial blood glucose (PPBG), and glycated hemoglobin (HbA1c), creatinine, albumin/creatinine ratio electrolytes (Na, K), and lipid parameters were recorded

Results: Mean age and BMI was 56.6±11.8 years, and 31.7±6.9 kg/m respectively. 97% of cohort had Type 2 DM. DM duration was 9.3±7.3 years in Type 1 and 8.1±7.2 years in Type 2. 20% of them were being treated with insulin, 26.5% with insulin and oral antidiabetics (OAD) and 53.5% with OAD. There was a significant relationship between the form of treatment and duration of diabetes (P<0.001). Insulin usage increases with increased DM duration. 31.9% retinopathy, 50.6% neuropathy, 37.1% nephropathy, 70.8% hypertension (HT), 69.8% hypercholesterolemia was detected. Chronic complications of DM were seen lesser in patients receiving OAD (63.4%) than receiving insulin or insulin and OAD (%85). Complication rates were increasing with aging (P<0,001) and longer duration of DM (P<0,001). The mean HbA1c was 8.1±2. Only 32% of patients had HbA1c<7%. As duration of DM prolonged, the ratio of well metabolic control were decreased (P<0.001). Metabolic control of the insulin users was worse than others (P<0.001).

Conclusion: These findings shows that metabolic control levels and follows-up of diabetics are generally poor. There is numerous medical and social factors that affect metabolic control so both of the patients and health personel should give adequate consideration to this matter.

Declaration of interest: The authors declare that there is no conflict of interest that could be perceived as prejudicing the impartiality of the research project.

Funding: This research did not receive any specific grant from any funding agency in the public, commercial or not-for-profit sector.